Přejít k obsahu
Merck
  • Novel splice site mutations and a large deletion in three patients with the cblF inborn error of vitamin B12 metabolism.

Novel splice site mutations and a large deletion in three patients with the cblF inborn error of vitamin B12 metabolism.

Molecular genetics and metabolism (2011-02-10)
Isabelle R Miousse, David Watkins, David S Rosenblatt
ANOTACE

The cblF disorder, characterized by accumulation of internalized cobalamin in the lysosome, is caused by mutations in the LMBRD1 gene which encodes an integral lysosomal membrane protein. We describe novel mutations in LMBRD1 in three patients: two splice site mutations, c.916-1G>T and c.1339-1G>T, and a 6785 bp deletion encompassing exon 2, c.70-4298_246+2311del6785. The three patients are compound heterozygotes for one novel mutation and the common c.1056delG mutation.